Amber company logo

Rewriting the Rules of Medicine

The Safe,


abstract gene image

& Precise Future

for Genetic Medicine

About Us

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.
The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population.
Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Amber gemAmber gem


Amber gemAmber gem


Amber gemAmber gem

Larger Edits

Our Values

Biologically Inspired

Biology is the most sophisticated and specialized form of technology accessible to our species. We humbly study biological systems, learn from them, and put them back together in new ways to build technologies to improve health.

Designed with Artisanship

We blend complex science with biological design. Our work is made possible by approaching biology through an artisan lens, allowing us to explore new avenues, discover novel connections, and advance meaningful paradigms.

Driven by Impact

We believe in a future where life’s most complex diseases are treated at scale. Gene therapies should be safe, easy, precise, and affordable. We work backwards from impact, building out a new frontier of genetic medicine.

Meet The Team

Supported by a vibrant and diverse group of scientists and industry experts. United by a shared vision of enhancing the therapeutic toolkit.

Basem Al-Shayeb, PhD

CTO and Co-Founder

David Schaffer, PhD


David Yao, PhD

Bioarchitect I

Dylan Cable, PhD

ML Researcher

Fei Chen, PhD


Gene Yeo, PhD


Jacob Borrajo, PhD

CEO and Co-Founder

Jim Griffin, PhD

Computational Biologist III

Jory Bell

Board Member

Kaisle Hill

Biodesigner II

Kamyab Javanmardi, PhD

Senior Bioarchitect

Melissa Jurica, PhD


Paul Blainey, PhD


Susan St Martin

Bioarchitect I Interim Lab Manager

Vineeta Agarwala, MD, PhD

Board Member

Made Possible With